About this trial
A head-to-head comparison of two different types of percutaneous mechanical thrombectomy (PMT) - ClotTriever System versus aspiration thrombectomy (including rheolytic thrombectomy) - in patients with acute iliofemoral deep vein thrombosis (DVT) was conducted to determine whether ClotTriever System can improve thrombus clearance rate, reduce the incidence of post-thrombotic syndrome (PTS), and enhance the long-term efficacy of endovascular treatment for acute iliofemoral DVT.
Eligibility criteria
Qualifiers
Aged between 18 and 85 years;
Diagnosed with acute iliofemoral venous thrombosis, with thrombosis involving at least the iliac vein and common femoral vein;
Time from symptom onset to endovascular treatment ≤ 14 days;
Patients undergo endovascular treatment with percutaneous mechanical thrombectomy;
Disqualifiers
Presence of PTS in the limb to be treated in this procedure, or a history of symptomatic DVT in the same limb within the past 2 years;
Concurrent symptomatic acute DVT involving the iliac vein and/or common femoral vein in the contralateral limb;
Known allergy to heparin, low molecular weight heparin, contrast agents, etc.
Concomitant severe pulmonary embolism with hemodynamic changes, such as hypoxia, hypotension, etc.
Trial design
Treatments tested in this trial
- Percutaneous mechanical thrombectomy by ClotTriever System
- Percutaneous mechanical thrombectomy by aspiration or rheolytic thrombectomy
Treatment groups
Sponsors and collaborators
RenJi Hospital
Lead sponsor
Changhai Hospital
Collaborator
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Collaborator
Wenzhou Central Hospital
Collaborator
West China Hospital
Collaborator
Chengdu University of Traditional Chinese Medicine
Collaborator
First People's Hospital of Hangzhou
Collaborator